Use of proton pump inhibitors and adverse clinical outcomes. | Br J Clin Pharmacol;88(5): 2452-2453, 2022 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Use of proton pump inhibitors and adverse clinical outcomes.

Wu, Dan-Na; Li, Guo-Fu; Yu, Guo.

Wu DN; Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, China.
Li GF; Clinical Medical College, Yangzhou University, Yangzhou, China.
Yu G; Clinical Medical College, Yangzhou University, Yangzhou, China.

Br J Clin Pharmacol ; 88(5): 2452-2453, 2022 05.

Article in English | MEDLINE | ID: covidwho-1788831

Subject(s)

Proton Pump Inhibitors; Humans; Proton Pump Inhibitors/adverse effects

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proton Pump Inhibitors Type of study: Prognostic study Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2022 Document Type: Article Affiliation country: Bcp.15161

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proton Pump Inhibitors Type of study: Prognostic study Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2022 Document Type: Article Affiliation country: Bcp.15161